HCV Case - Understanding Patterns of Hepatitis C Transmission in a Rural Community - Elizabeth Gatley, MBChB, FCP (SA)

Conference on Liver Disease in Africa (COLDA) 2022

HBV Case - When is it NOT Acute Hepatitis B? - Sandy Mosenye, Bsc( Med Science), MBChB, MMed, FCP(SA)

Conference on Liver Disease in Africa (COLDA) 2022

State-of-the-Art Lecture: HBV Cure - Geoffrey Dusheiko, MBBS, FCP(SA) FRCS

Conference on Liver Disease in Africa (COLDA) 2022

An Assessment of Metabolic Syndrome and Cardiovascular Risk Scores Among Patients With Non-alcoholic Fatty Liver Disease (NAFLD) at the Cape Coast Teaching Hospital, Ghana - Ansumana Bockarie

Conference on Liver Disease in Africa (COLDA) 2022

Prevalence and Mortality Trends of Hepatitis B and Hepatitis C Infection in Sub-Saharan Africa: A Systematic Analysis for the Global Burden of Disease Study 2020 - Hannah Han

Conference on Liver Disease in Africa (COLDA) 2022

Performance-Based Approach to Accelerate Hepatitis C Elimination in Rwanda - Janvier Serumondo

Conference on Liver Disease in Africa (COLDA) 2022

Hepatitis C Laboratory Data Analysis on Patients Seeking Medical Attention in the Public Health Sector, South Africa, 2017-2021 - Morubula J Manamela

Conference on Liver Disease in Africa (COLDA) 2022

Hepatitis Delta Virus Co/Super-Infection Surveillance among Clinicians: An Often- Neglected Practice in Nigeria - Ijeoma Ifeorah

Conference on Liver Disease in Africa (COLDA) 2022

Hepatitis B Infection Prevalence, Genotype Distribution, and Knowledge of Mother- To-Child Transmission Among Antenatal Care Attendees in Yako, Rural Burkina Faso - Serge Ouoba

Conference on Liver Disease in Africa (COLDA) 2022

Hepatitis B Birth Dose Coverage Remains Dramatically Low in the Gambia and Has Been Disrupted by the COVID-19 Pandemic - Gibril Ndow

Conference on Liver Disease in Africa (COLDA) 2022

5-Year Results of a Treatment Program for Chronic Hepatitis B in Ethiopia - Hailemichael Desalegn Mekonnen

Conference on Liver Disease in Africa (COLDA) 2022

Integrating hepatitis B into HIV programs in sub-Saharan Africa: pilot clinic experience in Zambia - Wamundila Kawana

Conference on Liver Disease in Africa (COLDA) 2022

Can Integration Reduce Stigma? / Lessons Learned from HIV - Danjuma Adda, MPH, FIMS, Dip-IMS

Conference on Liver Disease in Africa (COLDA) 2022

Integrated Decentralized Guidelines for Care – WHO Guidelines - Philippa Easterbrook, MD, FRCP, MPH, DTM&H

Conference on Liver Disease in Africa (COLDA) 2022

Modelling Elimination Strategies in Africa - Shevanthi Nayagam, MBBS, MRCP, PhD

Conference on Liver Disease in Africa (COLDA) 2022

Vertical Transmission, Maternal Care, and Family Care - Manal El-Sayed, MD, PhD

Conference on Liver Disease in Africa (COLDA) 2022

Blood Safety & Surveillance - Yuyun S. Maryuningsih, MD, PhD

Conference on Liver Disease in Africa (COLDA) 2022

From Pandemic Response to Pandemic Recovery - Opportunities for Viral Hepatitis Elimination - John Ward, MD

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “Call for Action - “We Need Testing and Treatment - NOW” - Bisi Bright, B.Pharm(Hons), MPH, FPCPharm, FPSN, C.Psych

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “We Need Solutions” - Agnes Binagwaho, MD, M(Ped), PhD

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “We Need (HQ) Data - To Plan Services” - Olufunmilayo Lesi, MD, MBA, FMCP

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “We Need to Address the Challenges - Now” - The South African Experience - Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD

Conference on Liver Disease in Africa (COLDA) 2022

Community Perspective - Michael Meulbroek

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

DDIs Relevant for COVID-19 Therapeutic Agents & Implementation Challenges - Fiona Marra, MPharm, MSc

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022